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INTRODUCTION
Population rise, inadequate supply of drugs, high cost of 
treatment, side effects, and drug resistance have led to increased 
Wound‑healing Activity of the Aqueous Leaf Extract and 
Fractions of Ficus exasperata (Moraceae) and its Safety 
Evaluation on Albino Rats
Victoria Nonyelum Umeh1, Emmanuel Emeka Ilodigwe1, Daniel Lotanna Ajaghaku1, 
Earnest Oghenesuvwe Erhirhie2, Goodies Emuesiri Moke2, Peter Achunike Akah3
1Department of Pharmacology and Toxicology, Nnamdi Azikiwe University, Awka, Anambra State, Nigeria.
2Department of Pharmacology and Therapeutics, Faculty of Basic Medical Sciences, Delta State University, Abraka, Delta State, Nigeria.
3Department of Pharmacology and Toxicology, University of Nigeria, Nsukka, Nigeria.
ABSTRACT
Ficus exasperata have been reported to have wide applications in the treatment of many human diseases. However, its traditional use in the 
treatment of wounds has not been validated by any scientific study. Also, its safety in the management of chronic disease conditions requires 
attention. We evaluated the wound‑healing activity of the aqueous extract and fractions of F. exasperata, as well as its safety after subchronic 
oral administration. Similar percentage of wound contraction was observed with 5% w/w extract ointment application  and administration 
of cicatrin powder (standard) on the 4th day, while better contraction than the standard was recorded with higher concentrations of the extract 
ointment. Of all the fractions tested, significant (P < 0.05) contraction was only noticed in chloroform fraction, though lower than that of 
the aqueous extract. The extract also showed concentration‑dependent inhibition of all the tested microbial isolates. Extract administered 
up to 5000 mg/kg (single dose administration) did not cause any mortality after 24 h. Mortality was, however, recorded at 4000 mg/kg 
within the first 20 days of subchronic administration of the extract. Significant (P < 0.05) increases in alanine aminotransaminase (ALT), 
aspartate aminotransaminase (AST), and in particular, alkaline phosphatase (ALP) were observed at different doses and time periods. 
Pathological and histological changes were noticed in the liver and kidney on the 91st day of the study with 4000 mg/kg of the extract. 
Except for the significant (P < 0.05) reduction in WBC on the 91st day, no other significant (P < 0.05) changes were observed in other 
hematological parameters. The aqueous extract demonstrated better wound‑healing activity than its fractions; however, the extract may 
not be safe at higher doses for subchronic oral administration, as may be the case in the management of chronic disease conditions.
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use of plant materials as a source of medicine for various human 
ailments.[1] The valuable medicinal properties inherent in plants 
have long been acknowledged, as biologically active molecules 
and lead structures for the development of modified derivatives 
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with enhanced activity have been obtained through various natu‑
ral product researches.[2] It is not therefore surprising that over 
three‑quarters of the world population rely mainly on plants and 
plant extracts for health care.[3]
Ficus exasperata, popularly referred to as “sandpaper leaf 
tree,” finds wide application in ethnomedicine.[4] In African tra‑
ditional medicine, all the plant parts are considered medicinally 
important, but the leaves are much valued in the treatment of 
diseases.[5] The leaf extract has been shown to cause a significant 
decrease in hyperglycemia, polyurea, and hyperlipidemia and 
enhanced serum insulin levels in streptozotocin‑induced diabetic 
rats.[6] Reduced blood pressure and restoration of microanatomy of 
the blood vessels to almost normal levels have also been achieved 
using the leave extract of F. exasperata in spontaneously hyperten‑
sive and obese Zucker rats.[6,7] Hydro‑ethanol extract of the leaves 
of this plant has also been shown to exhibit radical scavenging 
activity comparable to n‑propyl gallate and also inhibits lipid 
peroxidation in rat brain.[8] Anti‑inflammatory,[9] antiarthritic,[8] 
antinociceptive,[9] anticonvulsant,[10] anxiolytic,[11] antiulcer,[12] 
antipyretic,[13] and antimicrobial[14] activities of the leaf extract 
have all been validated in numerous scientific studies.
In south‑eastern Nigeria, the leaves are mainly used for the 
treatment of topical wounds and for the management of diabetes 
and hypertension. Since no studies have been done to validate 
its wound‑healing activity and its safety in managing chronic 
ailments, we evaluated the wound‑healing activity of the aque‑
ous extract and fractions, as well as its safety after subchronic 
administration in albino rats.
MATERIALS AND METHODS
Plant materials
Leaves of F. exasperata were collected from Nibo town in 
Awka South Local Government Area, Nigeria and were authen‑
ticated by Dr. J. E. Amadi of the Department of Botany, Nnamdi 
Azikiwe University, Awka, Anambra state, Nigeria where a 
voucher specimen (PCG/423A/019) was kept.
Animals
Adult albino rats (150‑180 g) were obtained from the animal 
house, Department of Pharmacology and Toxicology, Faculty of 
Pharmaceutical Sciences, Nnamdi Azikiwe University. They were 
maintained in standard animal house conditions and were fed with 
growers feed (by Top feeds Nigeria Limited) and water ad libitum. 
All animal experiments were conducted in compliance with the 
National Institutes of Health (NIH) Guide for Care and Use of 
Laboratory Animals (Pub. No. 85‑23 Revised 1985) and approved 
by the Nnamdi Azikiwe University, Awka Ethical Committee for 
the use of laboratory animals.
Methods
Extraction and fractionation
The shade‑dried leaves were pulverized, cold macerated 
for 24 h, and filtered, and the filtrate was concentrated using 
freeze‑drier. Part of the freeze‑dried extract (100 g) was adsorbed 
on silica gel and eluted in succession with n‑hexane, chloroform, 
ethyl acetate, and methanol. The filtrate so obtained was evaporated 
to a constant weight using rotary evaporator at 40°C.
Qualitative phytochemical analysis
Screening for the presence of secondary metabolites was 
performed following standard phytochemical tests as described 
by Harborne.[15]
Antimicrobial evaluation
Agar well diffusion technique, as described by Adeniyi et al.,[16] 
was used. The bacterial isolates of Proteus mirabilis, Pseudomonas 
aeruginosa, Salmonella typhi, Staphylococcus aureus, Escherich-
ia coli, Klebsiella pneumonia, and Proteus vulgaris were used. 
The extract concentrations used were 10, 50, 100, 150, 200, and 
250 mg/ml at an equal volume of 1000 μl. Each  concentration was 
tested in triplicate and the zones of inhibition were measured in 
millimeters.
Wound healing evaluation
Formulation of herbal ointment
The medicated ointment was prepared by incorporating 
different quantities of the extract or fractions into the ointment 
base (composed of cetosteryl alcohol, hard paraffin, wool fat, and 
white soft paraffin) to get 5, 15, 20, and 25% w/w of the extract in 
ointment. Also 10, and 20% w/w of each fraction in ointment was 
prepared. The fusion method was adopted in the formulation of the 
herbal ointment. The required quantity of the ointment base was 
weighed and melted at a temperature of about 70°C in a water bath.
The designated quantity of the extract (or fraction) was added 
to the melted base at 40°C in a water bath, stirred gently and 
continuously until a homogenous dispersion was obtained. The 
above exercise was repeated using different weights of the crude 
extract (or fractions) in order to obtain the above‑mentioned 
concentrations.
Wound creation
Thirty adult albino rats divided into six groups of five rats 
each were used for the study. Excision wounds were created after 
shaving the left dorsal thoracic region 1 cm away from the vertebral 
column and 5 cm away from the ear. The animals were anesthetized 
prior to and during creation of wounds with chloroform using open 
mask method. Excision wounds of about 3 cm in diameter were 
created. All wounds were of full thickness, extending down to 
adipose tissue.[17] The wound areas were measured every 4 days by 
retracing the wound on a millimeter scale graph paper,[18] cleaned 
with methylated spirit, and the appropriate ointment concentration 
applied once a day until complete healing was observed. Wound 
contraction was calculated as percentage reduction in the wound 
area with respect to the initial wound area, while epithelializa‑
tion time was noted as the number of days required after wound 
infliction for the scab to fall off leaving no raw wounds behind:
AT W% =   100
 −
× 
 
A0
A0
W
Wound Contraction
W
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where
W
A0
 = wound area on day 0
W
AT 
= wound area on day T (after induction).
Acute toxicity test
Acute oral toxicity test was conducted as per the Organisa‑
tion for Economic Co‑operation and Development (OECD) 
guidelines 423.[19] A total of 18 albino mice were divided into 
three groups of six animals each. The control group received 
10 ml/kg of normal saline, while the second and third groups 
received a single dose of 2000 and 5000 mg/kg of the extract, 
respectively. The animals were observed for obvious signs of 
toxicity and mortality at hourly intervals for the next 24 h and 
thereafter for a total of 14 days.
Subchronic toxicity test
Sixty albino rats were divided into four groups as A, B, C, 
and D, with each group consisting of 15 rats. After pre‑treatment 
and determination of basal biochemical and hematological 
parameters, groups B, C, and D received the extract orally at 
doses of 1000, 2000, and 4000 mg/kg, respectively, daily for 
90 days. Group A served as negative control and received 10 ml/
kg normal saline. Physical observation of the animals was done 
on a daily basis.
Five rats from each group were anesthetized using chloroform 
on the 31st, 61st, and 91st days of the study. Blood samples were 
collected through retro‑orbital plexus and used for the estima‑
tion of hemoglobin (Hb), packed cell volume (PCV), red blood 
cell (RBC) and white blood cell (WBC) count.[20] Serum samples 
were used for analysis of biochemical markers, i.e. alanine ami‑
notransaminase (ALT),[21] aspartate aminotransaminase (AST),[21] 
and alkaline phosphatase (ALP).[22] Histological studies were done 
on liver and kidney isolates from animals of different dose groups 
on the 91st day.
Statistical analysis
The data were expressed as mean ± SEM. The results were 
analyzed by SPSS version 19 using one‑way analysis of variance. 
Graphical representation was done using Microsoft Excel 2010. 
The differences between mean values were considered significant 
at P < 0.05.
RESULTS
Qualitative phytochemistry
Qualitative phytochemical study of the extract [Table 1] re‑
vealed the presence of many phytocompounds. Phlobatannins and 
terpenoids were found at a high concentration in the chloroform 
fraction, while alkaloids and saponins were more in the methanol 
fraction. Ethyl acetate fraction contained saponins, terpenoids, and 
flavonoids. The n‑hexene fraction was more of fats and oil. Due 
to the low percentage yield of n‑hexane fraction, no further study 
was done with this fraction.
Antimicrobial activities of the extract
Table 2 shows the results of the antimicrobial activities of dif‑
ferent concentrations of the aqueous crude extract on some human 
pathogens. There was a concentration‑dependent inhibition of all 
the tested micro‑organisms. The minimum inhibitory concentration 
of the leaf extract ranged from 10 to 250 mg/ml.
Wound‑healing activity
Progressive wound contraction was observed in all the 
extract‑treated groups [Figure 1]. At the lowest concentration of 
5% w/w extract ointment, significant (P < 0.05) contraction similar 
to that of cicatrin powder (standard) was observed on the 4th day. 
Better contraction than the standard was recorded at higher con‑
centrations of the extract ointment. Epithelialization was observed 
on the 11th day in the 20% and 25% w/w extract ointment treated 
groups, while it occurred on the 14th day in the cicatrin powder 
treated group just like the 15% w/w extract ointment treated 
group [Table 3]. The group treated with blank ointment took a 
longer time (24 days) to achieve epithelialization. Less contrac‑
tion activity was recorded for the fractions [Figure 2]. Only the 
chloroform fraction (20% w/w) showed significant contraction 
from the 12th day. Epithelialization time (14 days) for this fraction 
was, however, the same as that of cicatrin powder.
Acute toxicity test
No obvious physical and behavioral side effect was observed. 
Up to 5000 mg/kg, the extract did not cause any mortality after 24 h 
and subsequently for 14 days. The LD
50 
was, therefore, estimated 
to be greater than 5000 mg/kg.
Table 1. Phytochemical constituents of aqueous extract and fractions of Ficus exasperata
Phytoconstituents Crude extract Methanol fraction Chloroform fraction N‑hexene fraction Ethyl acetate fraction
Alkaloids + + + + +
Saponins ++ + ‑ ‑ +
Flavonoids + ‑ ‑ ‑ +
Glycosides + ‑ ‑ ‑ ‑
Tannins + ‑ ‑ ‑ ‑
Proteins ‑ ‑ ‑ ‑ ‑
Resins ‑ ‑ ‑ ‑ ‑
Steroids ‑ ‑ ‑ ‑ ‑
Phlobatannins + ‑ + ‑ ‑
Terpenoids ++ ‑ + ‑ +
Fats and oil + ‑ ‑ + ‑
Percentage yield (%) 23.69 22.40 2.68 0.66 21.64
The Key +: Present in trace amount, ++: Present in appreciable amount, ‑: Absent
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Figure 2. Wound‑healing activity of different fractions of aqueous leaf 
extract of F. exasperata.*P < 0.05 compared with control
Table 2. Inhibition zone diameters (mm) of F. exasperate against test 
microorganisms
Test 
isolates
Concentration (mg/ml)
250 200 150 100 50 10 Cicatrin powder 
(25 mg/ml)
P. mirabilis 11 ‑ ‑ ‑ ‑ ‑  11
P. aeruginosa 11 6 6 3 ‑ ‑  ‑
S. typhi 18 16 14 13 12 ‑  14
S. aureus 13 12 10 4 3 3  13
E. coli 9 5 4 4 3 2  12
K. pneumoniae 21 5 5 3 ‑ ‑  15
P. vulgaris 12 5 5 3 3 2  9
Table 3. Epithelialization time of the different formulated extract and 
fractions ointments
Treatment groups Mean epithelialization 
time (days)+SEM
Negative control (blank ointment) 24+1.8
5% W/W extract ointment 16+0.8
15% W/W extract ointment 14+0.5
20% W/W extract ointment 11+0.7
25% W/W extract ointment 11+0.5
10% W/W chloroform fraction ointment 20+1.0
20% W/W chloroform fraction ointment 14+0.6
10% W/W ethylacetate fraction ointment 24+1.2
20% W/W ethylacetate fraction ointment 22+0.9
10% W/W methanol fraction ointment 28+1.6
20% W/W methanol fraction ointment 28+1.8
Cicatrin powder (standard) 14+0.6
SEM: Standard error of mean
Subchronic toxicity tests
By day 17 of daily oral administration of the extract, obvious 
signs of weakness were observed in some of the rats that received 
4000 mg/kg of the extract and, subsequently, eight rats died in this 
group within the first 20 days. Thereafter, no death was recorded 
in all the groups. Significant (P ˂ 0.05) increase in ALT was ob‑
served only for the highest dosed group on the 61st and 91st days 
[Figure 3a]. Groups that received 2000 and 4000 mg/kg of the 
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Figure 1. Wound‑healing activity of the aqueous leaf extract of F. 
exasperata.*p < 0.05 compared with control
extract exhibited significant (P < 0.05) increase in AST on the 
61st day, while significant (P < 0.05) increase was observed with 
all doses on the 91st day [Figure 3b]. Also, significant (P < 0.05) 
increase in ALP was observed in all the extract‑treated groups on 
the 61st and 91st days. It was also observed that increase in ALP in 
the group treated with 4000 mg/kg became significant (P < 0.05) 
even on the 31st day [Figure 3c].
Histological changes in the liver of the highest dosed group 
correlated with the biochemical changes observed. Histology of the 
liver in this group showed proliferation of the tissue stroma, edema, 
dilatation, hemorrhage, and increased size of the hepatocytes 
[Figure 4]. Histology of the kidney of negative control revealed 
intact glomeruli. As the dose of the extract was increased (1000, 
2000, and 4000 mg/kg), there was a progressive decrease in the 
number of glomeruli [Figure 5]. Changes in the kidney histology 
became obvious in the group that received 4000 mg/kg b.wt. of the 
extract. Most glomeruli were either shrunken or lost, in addition to 
tubular hemorrhage occurring in this group. Hematological analy‑
sis revealed no significant (P ˃  0.05) changes in PCV [Figure 6a], 
Hb [Figure 6b], and RBC [Figure 6c] values in all the groups. 
Significant (P ˂ 0.05) decrease in the WBC was observed in all 
the extract‑treated groups on the 91st day [Figure 6d].
DISCUSSION
Wounds provide a conducive environment for the growth of 
micro‑organisms. Usually, microbial contaminants of wounds 
involve a variety of organisms such as P. aeruginosa, Sta. aureus, 
Streptococcus faecalis, E. coli, Clostridium perfringens, Clos-
tridium tetani, coliform bacilli, and enterococcus.[23,24] Evaluation 
of the extract in clinically isolated microbial contaminants of 
wounds showed dose‑dependent inhibitory activity against some 
pathogenic micro‑organisms including P. aeruginosa and Sta. au-
reus, two organisms mostly implicated in chronic and non‑healing 
wounds.[25] Microbial infection in wound delays healing and causes 
more pronounced acute inflammatory reaction which can lead to 
further tissue injury and damage.[24] Thus, the antimicrobial activity 
of the extract on these wound isolates may partly contribute to the 
wound‑healing effect by eliminating infection and thus allowing 
initiation of natural tissue repair processes. It also suggests the 
leaf extract may play useful role in accelerating the healing of old 
wounds by eradicating already established infection.
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Figure 3. Effects of extract on liver enzymes: (a) Alanine aminotransaminase, (b) Aspartate aminotransaminase and (c) Alkaline phosphatase. *p < 0.05 
compared with control
Phytochemical analysis of the extract and fractions revealed the 
presence of alkaloids, saponins, sterols, terpenoids, glycosides, tan‑
nins, and flavonoids. These metabolites are usually responsible for 
the pharmacological activities of medicinal plants.[26] Saponins and 
flavonoids have been reported to possess wound‑healing activity.[27] 
Terpenoids are known to promote wound‑healing process, mainly 
due to their astringent and antimicrobial activities which seem to be 
responsible for wound contraction and increased rate of epithelializa‑
tion.[28] Flavonoids and their derivatives are known to decrease lipid 
peroxidation by improving vascularity leading to slowing down of 
cell necrosis.[29] Phlobatannins have also been demonstrated to have 
wound‑healing activity.[30] Therefore, the wound‑healing potential of 
F. exasperata can be attributed to the contributions of individual phy‑
toconstituents. Synergistic or complementary effects of the phytocon‑
stituents were further demonstrated by higher activity recorded by the 
extract compared with the fractions. Significant activity recorded by 
the chloroform fraction indicates that phlobatannins may have played 
a significant role in the overall wound‑healing activity of the extract.
Figure 4. Liver histology. (a) Negative control, with normal liver histology, 
(b) no significant changes observed with 100 mg/kg, (c) proliferation of 
the tissue observed with 2000 mg/kg, (d) proliferation of the tissue stroma, 
oedema (p), dilatation and haemorrhage within the central vein (v), increase 
in size of the hepatocytes (h) observed with 4000 mg/kg
dc
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Figure 5. Kidney histology. (a) Negative control with normal features, 
(b) 1000 mg/kg of extract with no significant change, (c) 2000/kg of extract 
with no significant change, (d), 4000 mg/kg of extract showing significant 
damages: oedema (H), shrunken /loss of glomeruli(S), haemorrhage (H), 
tissue stromal distortion(S)
dc
ba
Figure 6. Effects of extract on haematological parameters: (a) Packed cell volume (PCV), (b) Hemoglobin (HB), (c) Red blood cell (RBC) and 
(d) White blood cell (WBC). *p < 0.05 compared with control
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Conventional wound treatment requires, more or less, the 
combined effects of antibiotics, anti‑inflammatory agents, astrin‑
gents, and antipyretics; F. exasperata has been reported to possess 
antibacterial,[14] anti‑inflammatory,[9] antioxidant,[8] and antipyretic 
effects.[13] The extract can, therefore, be effectively used in the 
treatment of wounds.
Single administration of the extract up to 5000 mg/kg did not 
produce any sign of toxicity or mortality, an indication that may 
have led to the assumption that the extract is safe. However, this 
was not the case observed on subchronic administration, as obvi‑
ous signs of toxicity and mortality were recorded within the first 
20 days in the highest dosed group. These signs alerted us of the 
inherent toxicity that may be associated with this extract.
ALT, AST,   and ALP are the enzymes associated with liver 
function and are an indirect measure of liver homeostasis.[31] El‑
evation of these marker enzymes is an indication of hepatotoxicity 
associated with the extract. It was observed that elevation of ALP 
preceded that of other marker enzymes. ALP elevation is usually 
associated with cholestasis due to biliary obstruction or hepatic 
infiltration,[32] which may be a key to hepatotoxicity associated with 
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this extract. Biochemical alterations observed were complemented 
by histological changes in the liver and kidney. This is in line with 
the observed increases in liver and kidney weights as well as serum 
liver enzymes reported following acute administration of aqueous 
extract of F. exasperata.[33] Also, Bwititi et al.[34] and Ijeh and Uk‑
weni[35] have indicated toxic injury to the kidney following acute 
exposure to F. exasperata. The toxicity of F. exasperata leaf  has 
been attributed to its high content of cyanogenic glycosides[36] and 
may have contributed to the observed toxicity recorded in this study.
Hematological system is highly susceptible to drug‑induced 
toxicity due to its vital position and functions.[37] The reduction in 
WBC on the 91st day in all the extract‑treated groups may be due 
to the direct destructive effect of the extract on these cells or their 
impaired production in the hematopoietic tissues (bone marrow). 
Moreover, the reduction of WBC following extract treatment might 
be because of the mobilization of the leukocytes to  the tissues 
surrounding the blood.
CONCLUSION
The present study justified the use of the leaf extract of F. ex-
asperata in the treatment of cutaneous wounds more than any of 
its fractions. However, F. exasperata may not be safe at higher 
doses, especially for the management of chronic disease condi‑
tions like hypertension and diabetes, as could be observed in the 
subchronic toxicity and histopathology findings.
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